Speaker(s): TBA, Feedback from Audience.

• Focus: A collaborative environment for participants to share their hands-on experiences, insights, and best practices related to the use of AI in the pharmaceutical R&D lifecycle.

• Expected Format: Could include short presentations by community members, panel discussions, Q&A sessions, and a general forum for discussing practical challenges and solutions when implementing AI in drug discovery.

• Series Context: The final event in the "AI IN PHARMACEUTICAL INDUSTRY" series, aimed at consolidating learnings and fostering a community of practice.